- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07336108
RUG-WEAVING PLICATION IN CYSTOCELE TREATMENT
January 2, 2026 updated by: Rahime Bedir Fındık, Ankara City Hospital Bilkent
RUG-WEAVING PLICATION TECHNIQUE RESULTS IN CYSTOCELE TREATMENT:TWO YEAR FOLLOW-UP
In this study was to compare the 2-year results of the Rug Wave plication technique, which it present as a natural tissue repair technique in cystocele, with the conventional technique in terms of both recurrence and patient quality of life satisfaction scales.
Study Overview
Status
Completed
Conditions
Detailed Description
The study was planned as a retrospective case-control observational study.
It included 60 patients who underwent surgery solely for cystocele or cystocel with other organ prolapse conditions; of them, 29 received the rug-weaving plication technique, a natural tissue repair method implemented for anterior wall defects since 2022, and 31 underwent conventional anterior colporrhaphy.Data were collected in 2 groups.
In Group 1, there were data of 29 patients who were operated for cystocele with the Rug Wave technique and Group 2, there were data of 31 patients who were operated with the classical colporrhaphy technique.
Data from these patients were recorded at 6 months and 2 years postoperatively.
At the 6 months and 2 years postoperative follow-up, it assessed patients' complaints, degree of prolapse (using the simplified Pelvic Organ Prolapse Quantification system), pelvic floor muscle strength (using the Modified Oxford Score) and the anterior vaginal wall thickness in transvaginal ultrasound.
In addition, the data of the questionnaire applied to the patients in the 2nd year were also recorded(Pelvic Floor Distress Inventory, Sandvik Severity Index, Overactive bladder, Surgical satisfaction questionnaire, Patient global impression of improvement questionnaire, Pelvic Organ Prolapsed / Urinary Incontinence Sexual Questionnaire, Incontinence Impact Questionnaire).The results of the two groups were compared.Data were entered and analyzed in SPSS program.
Mann-Whitney -U test, Independent simple test, Chi-Square test were used in group comparisons.
Chi-Square test was used to compare categorical variables; Mann-Whitney U test was used to compare continuous variables that were not normally distributed; Independent Simple test was used to evaluate the significance of the differences between the means of continuous variables between two groups.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ankara
-
Ankara, Ankara, Turkey (Türkiye), 06200
- Ankara Bilkent City Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Women operated on for anterior wall prolapse in POP-Q
Description
Inclusion Criteria:
- Patients operated on using the rug weaving plication technique
- Patients operated on using the conventional anterior colporrhaphy
Exclusion Criteria:Patients who did not undergo cystocele surgery were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1:there were data of 29 patients who were operated for cystocele with the Rug Wave techniq
Rug Waiving plication techniqe
|
Rug Waeving plication technique :This technique is a technique that has not been used before.
|
|
Group 2: 31 patients who underwent surgery using conventional colporrhaphy.
anterior vaginal wall repair with theconventional technique in cystosel
|
Patients operated on using the conventional anterior colporrhaphy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pelvic Organ Prolapse Quantification (POP-Q) Postoperative anterior wall POP-Q
Time Frame: 2 years
|
The POP-Q staging system, introduced in 1996 and widely accepted as the standard quantitative classification system for pelvic organ prolapse, was utilized in this study.
Measurements were conducted with a scaled abeslang while the patient was in the lithotomy position.
Evaluation of the anterior compartment involved measuring points Aa and Ba, the apical compartment involved points C and D, and the posterior compartment involved points Ap and Bp.
Staging was determined based on the lowest point of prolapse.
Stage 0 indicated normal pelvic floor support, Stage 2 indicated a distance between -1 and 1 from the hymen, and Stage 4 indicated total uterine prolapse (prosidentia).
Stages 1,2 and 3 indicated intermediary levels of prolapse severity, counting for grades between Stage 0 and 4. Figure -1 schematically shows the POP-Q staging system .
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2025
Primary Completion (Actual)
December 15, 2025
Study Completion (Actual)
December 15, 2025
Study Registration Dates
First Submitted
December 16, 2025
First Submitted That Met QC Criteria
January 2, 2026
First Posted (Actual)
January 13, 2026
Study Record Updates
Last Update Posted (Actual)
January 13, 2026
Last Update Submitted That Met QC Criteria
January 2, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- There is no sponsor.
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
due to patient privacy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystocele
-
Medical University of ViennaRecruitingPelvic Organ Prolapse | Cystocele | Vaginal Prolapse | Cystocele, Midline | Prolaps BladderAustria
-
National Taiwan University HospitalCompletedLower Urinary Tract Symptom in Severe Cystocele Women
-
Zagazig UniversityCompletedProlapse, Vaginal | Paravaginal Cystocele
-
Karolinska InstitutetStockholm County Council, Karolinska Institutet research foundations, Swedish...CompletedSurgical Repair of Middle Compartment Prolapse (Vaginal Vault or Uterine Prolapse) With or Without Cystocele
-
National Taiwan University HospitalCompletedUrodynamic Stress Incontinence in Severe Cystocele Women
-
The Cleveland ClinicCompletedPelvic Organ Prolapse
-
Charles University, Czech RepublicRecruitingPelvic Organ Prolapse | Cystocele | Cystocele and Incomplete Uterovaginal ProlapseCzechia, Slovakia
-
Atrium Medical CenterMaastricht UniversityUnknown
-
Mount Sinai Hospital, CanadaCompleted
-
Ain Shams Maternity HospitalCompleted
Clinical Trials on rug weaving-like plication technique
-
Ankara City Hospital BilkentCompleted
-
University Hospital, Clermont-FerrandCompletedPneumothorax | Hemothorax | Pleural EffusionFrance
-
Massachusetts General HospitalRecruiting